AstraZeneca’s former head of its China business has been formally charged by the country’s authorities with illegal trading, unlawful collection of personal information and medical insurance fraud, alongside another former employee.
阿斯利康(AstraZeneca)前manbetx3.0 区负责人及另一名前员工已被manbetx3.0 有关部门正式指控非法进口药物、非法收集个人信息和医疗保险欺诈。
您已阅读10%（298字），剩余90%（2571字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。